FDA Approved: CAMCEVI — Supplemental Application (Accord BioPharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CAMCEVI (leuprolide) from Accord BioPharma, Inc., expanding regulatory approval for this long-acting leuprolide prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• CAMCEVI (leuprolide)

Snippet

SUPPL AP for CAMCEVI (LEUPROLIDE)